Besides, MS13 treatment in DU 145 and PC-3 cells has shown the downregulation of PPP3CB, TFDP1, SMAD3, and ENDOG, which the anti-cancer activity have not been reported in PCa but noted in other cancers. Here, ENDOG is linked to posterior cortical atrophy.